The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 27, 2014
Filed:
Sep. 14, 2012
Somasekhar Bhamidipati, Foster City, CA (US);
Jeffrey Clough, Redwood City, CA (US);
Ankush Argade, Foster City, CA (US);
Rajinder Singh, Belmont, CA (US);
Vadim Markovtosov, Foster City, CA (US);
Pingyu Ding, Foster City, CA (US);
Jiaxin Yu, San Carlos, CA (US);
Andy Atuegbu, Dublin, CA (US);
Hui Hong, Palo Alto, CA (US);
Ihab Darwish, San Carlos, CA (US);
Sambiah Thota, Fremont, CA (US);
Somasekhar Bhamidipati, Foster City, CA (US);
Jeffrey Clough, Redwood City, CA (US);
Ankush Argade, Foster City, CA (US);
Rajinder Singh, Belmont, CA (US);
Vadim Markovtosov, Foster City, CA (US);
Pingyu Ding, Foster City, CA (US);
Jiaxin Yu, San Carlos, CA (US);
Andy Atuegbu, Dublin, CA (US);
Hui Hong, Palo Alto, CA (US);
Ihab Darwish, San Carlos, CA (US);
Sambiah Thota, Fremont, CA (US);
Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);
Abstract
This invention is directed to compounds of formula (I): where n, m, Y, R, R, R, Rand Rare disclosed herein, as isolated stereoisomers or mixtures thereof, or pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising the compounds of formula (I); and methods of using the compounds and the pharmaceutical compositions in treating diseases or conditions associated with JAK2 activity.